Top Markets
#1 EXOD EXOD +56.80%
#2 MowCat MowCat +48.22%
#3 Glidr Glidr +36.87%
#4 CoW Protocol CoW Protocol +34.95%
#5 Humanity Humanity +26.29%
#6 Codatta Codatta +19.83%
#7 Walrus Walrus +18.24%
#8 Enso Enso +17.51%
#9 RedStone RedStone +16.76%
#10 Collector Crypt Collector Crypt +14.50%
Coin of the day
EXOD EXOD
Instellingen
Taal
DUTCH
Valuta
USD
Thema
Core One Labs Inc. Core One Labs Inc.

Core One Labs Inc.

COOL
Rang in aandelen #36380
Core One Labs Inc. functions as a biotechnology research and life sciences... Core One Labs Inc. functions as a biotechnology research and life sciences firm. Its primary objective involves bringing psychedelic medications to the market, employing several key strategies. These include developing innovative delivery methods, offering psychedelic-assisted psychotherapy, and manufacturing API-grade psilocybin. The company also developed CannaStrips technology, which facilitates the bioavailability of cannabis compounds through infused strips. Complementing its core activities, Core One Labs provides a range of additional services such as consulting, financing, and micro cultivation support. It further operates medical and wellness clinics, supplies natural health products, and offers news dissemination services. Established in 2010, the company, formerly known as Lifestyle Delivery Systems Inc., adopted its current name in September 2019 and is headquartered in Vancouver, Canada.
Aandeelprijs
$0.10745118
Laatst gesynchroniseerd: 2024-08-30
Marktkapitalisatie
$2.75M
Verandering (1 dag)
-0.06%
Verandering (1 jaar)
0.00%
Land
CA
Handel Core One Labs Inc. (COOL)

Categorie

Healthcare
Winst voor Core One Labs Inc. (COOL)
Winst in 2026 TTM: 0
Volgens de meest recente financiële verslagen van Core One Labs Inc. bedraagt de huidige winst van het bedrijf 0. In 2026 behaalde het bedrijf een winst van 0, gelijk aan de winst van 2026, die 0 bedroeg. De weergegeven winst op deze pagina is de winst vóór rente en belastingen, oftewel EBIT.
Winstgeschiedenis van Core One Labs Inc. van 2026 tot 2026
Winst aan het einde van elk jaar
Jaar Winst Wijzigen
Niet genoeg gegevens voor de verstrekte datums.
Winst van vergelijkbare bedrijven of concurrenten
Bedrijf Winst Winstverschil Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
- -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
$3.01B -
BE